研发工程师
深圳市伯劳特生物制品有限公司
- 公司规模:50-150人
- 公司性质:民营公司
- 公司行业:制药/生物工程
职位信息
- 发布日期:2021-01-05
- 工作地点:深圳-南山区
- 招聘人数:2人
- 工作经验:3-4年经验
- 学历要求:硕士
- 职位月薪:10-20万/年
- 职位类别:医疗器械研发 生物工程/生物制药
职位描述
1、负责化学发光平台的建立与优化,包括微粒偶联、标记物标记、检测工艺、系统配方、发光底物等技术引进和摸索;
2、负责化学发光产品研发和升级改进,推动项目快速有效地进行,分析评价和改进产品;
3、负责相关项目的文献资料收集、整理和分析;
4、分析与解决客户反馈的问题;
5、培训新员工,撰写转产产品SOP;
6、完成上级临时安排的其他相关工作。
任职要求:
1. 硕士及以上学历,生物学、免疫学、化学、医学检验等相关专业。
2. 3年以上化学发光试剂产品开发及注册经验。作为主要负责人成功开发过2个以上已上市的化学发光体外诊断试剂产品。
3. 精通化学发光免疫检测技术;掌握完整的试剂产品开发、注册流程,熟悉法规要求;熟悉体外诊断行业,具备丰富的体外诊断试剂产品临床应用相关知识。
4. 有较强的进度意识,和责任终点意识;能合理进行任务分解制定工作计划,推动任务完成。
5. 积极主动、敬业踏实,有较强的团队合作意识。
6. 能承担工作压力。
7. 工作地点:深圳南山区
公司介绍
深圳市伯劳特生物制品有限公司成立于1999年1月,是国家及深圳市认定的高新技术企业。公司成立之日起就致力于从事免疫印迹诊断试剂的研发和产业化,拥有按照国家体外诊断试剂生产管理法规要求建立的十万级别净化车间、现代化实验室、仓库物流库房,购置了现代化的实验、检测和生产设备,先后获得国家医疗器械生产许可、经营许可及德国TUV莱茵公司ISO13485:2003质量体系。2007年,公司合作项目《幽门螺杆菌关键治病因子CagA、VacA的生物特性及其临床应用》荣获国家科学技术进步二等奖(证书号:2007-J-233-2-01-R08)。目前,公司拥有糖尿病自身抗体免疫印迹试剂盒(免疫印迹法)、风湿病自身抗体免疫印迹试剂盒(免疫印迹法)、幽门螺杆菌抗体分型检测试剂盒(免疫印迹法)、风湿病自身抗体检测试剂盒(斑点印迹法)等多个自主知识产权产品,其中,幽门螺杆菌抗体分型检测试剂盒(免疫印迹法)获得2012年度科技部科技型中小企业技术创新基金立项支持。
公司注重知识产权领域的保护,目前已拥有发明专利四项(改良罗氏快速培养基及其制备方法: ZL 2008 1 0099812.0,一种用于糖尿病自身抗体6项联检试剂盒: ZL 2012 1 0486571.1,降钙素原检测试纸条及其制备方法:ZL 2012 1 0498784.6 ,一种幽门螺杆菌分型检测的试剂盒:ZL 2015 1 0033662.3),在申请并已进入实审阶段发明专利三项。
2015年度,我司实现年产销各类诊断试剂逾10万盒,客户涵盖各等级医疗机构、科研机构、专业体检机构和第三方检测机构,市场辐射全国各大主要城市,继续保持较为高速的增长势头,并逐步形成了集自主研发、生产、销售体外诊断试剂为一体的完整产业链。
Founded in 1999, Shenzhen Blot Biological Products Co., Ltd. is a national high-tech enterprise specializing in the research, development and production of in vitro diagnostic reagents. The company is headquartered in Shenzhen and has R&D facilities in the United States. The company relies on years of technical reserves, and cooperates with professional institutions and experts to build a multi-directional, multi-platform, multi-variety IVD product development and production system; the company had completed the basic research project: "Helicobacter pylori key pathogenic factor CagA, VacA and clinical application” , which show VacA and CagA are key pathogenic factors of Helicobacter pylori. The contribution had been granted he second prize of National Science and Technology Progress Award; Our main products: “Helicobacter pylori antibody typing test kit” (immunoblotting) not only confirms the presence of Helicobacter pylori infection, but also further evaluates the virulence and pathogenicity of bacteria, helping clinical precision diagnosis and treatment and avoiding over-medical treatment. Such product finally contribute the rational allocation of medical resources , the deterioration of antibiotic resistance of Helicobacter pylori, and significantly benefit health, economic..
公司注重知识产权领域的保护,目前已拥有发明专利四项(改良罗氏快速培养基及其制备方法: ZL 2008 1 0099812.0,一种用于糖尿病自身抗体6项联检试剂盒: ZL 2012 1 0486571.1,降钙素原检测试纸条及其制备方法:ZL 2012 1 0498784.6 ,一种幽门螺杆菌分型检测的试剂盒:ZL 2015 1 0033662.3),在申请并已进入实审阶段发明专利三项。
2015年度,我司实现年产销各类诊断试剂逾10万盒,客户涵盖各等级医疗机构、科研机构、专业体检机构和第三方检测机构,市场辐射全国各大主要城市,继续保持较为高速的增长势头,并逐步形成了集自主研发、生产、销售体外诊断试剂为一体的完整产业链。
Founded in 1999, Shenzhen Blot Biological Products Co., Ltd. is a national high-tech enterprise specializing in the research, development and production of in vitro diagnostic reagents. The company is headquartered in Shenzhen and has R&D facilities in the United States. The company relies on years of technical reserves, and cooperates with professional institutions and experts to build a multi-directional, multi-platform, multi-variety IVD product development and production system; the company had completed the basic research project: "Helicobacter pylori key pathogenic factor CagA, VacA and clinical application” , which show VacA and CagA are key pathogenic factors of Helicobacter pylori. The contribution had been granted he second prize of National Science and Technology Progress Award; Our main products: “Helicobacter pylori antibody typing test kit” (immunoblotting) not only confirms the presence of Helicobacter pylori infection, but also further evaluates the virulence and pathogenicity of bacteria, helping clinical precision diagnosis and treatment and avoiding over-medical treatment. Such product finally contribute the rational allocation of medical resources , the deterioration of antibiotic resistance of Helicobacter pylori, and significantly benefit health, economic..
联系方式
- Email:2799940246@qq.com
- 公司地址:地址:span月亮湾大道2076号中国高科大厦D座六楼